Darrow Zeidenstein was named chief development officer at the American Cancer Society and its advocacy affiliate the American Cancer Society Cancer Action Network. In this role, Zeidenstein will lead the organization’s development efforts, overseeing all aspects of resource generation, including corporate partnerships, philanthropy, planned giving, Discovery Shops, community-based fundraising, and revenue-generating field operations.
Amid deepening controversy, Vinay Prasad, FDA’s top clinician and scientist, and director of its Center for Biologics Evaluation and Research, will be leaving the agency.
